We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Adage Capital Reports 7.48% Stake in Helus Pharma

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed an amended Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of Common Shares of Helus Pharma Inc. as of September 30, 2026.

Aditi Sarkar | 12 November 2026

Adage Capital Cuts Tenax Therapeutics Stake to 2.26%

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed Amendment No. 2 to Schedule 13G with the SEC on November 12, 2026, disclosing a 2.26% beneficial ownership position in Tenax Therapeutics, Inc. as of September 30, 2026.

Vinay Lochav | 12 November 2026

Adage Capital Discloses 7.62% Stake in Viking Acquisition Corp. II

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of Class A Ordinary Shares in Viking Acquisition Corp. II as of September 30, 2026.

Nitish Kishor | 12 November 2026

Adage Capital Discloses 7.61% Stake in Columbus Circle Capital III

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G on November 12, 2026, disclosing beneficial ownership of 1,800,000 Class A Ordinary Shares of Columbus Circle Capital Corp III as of September 30, 2026.

Nitish Kishor | 12 November 2026

Adage Capital Discloses 5.81% Stake in First Tracks Biotherapeutics

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing a 5.81% beneficial ownership position in First Tracks Biotherapeutics, Inc. as of September 30, 2026.

Aditi Sarkar | 12 November 2026

Adage Capital Discloses 8.74% Stake in Freedom Metals

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing a beneficial ownership position in Freedom Metals Acquisition Corp. as of September 30, 2026.

Nitish Kishor | 12 November 2026

BofA Finance Auto-Callable Notes Linked to EWZ Due 2031

BofA Finance LLC filed a free writing prospectus on November 12, 2026, disclosing terms for Market Linked Securities auto-callable with leveraged upside participation and contingent downside, principal at risk, linked to the iShares MSCI Brazil ETF and due November 17, 2031.

Anjali Anand | 12 November 2026

Morgan Stanley MSFL Note Linked to Alphabet, Due 2028

Morgan Stanley Finance LLC filed a free writing prospectus on November 12, 2026, for Market Linked Securities linked to the Class A common stock of Alphabet Inc., with a maturity date of November 24, 2028, fully and unconditionally guaranteed by Morgan Stanley.

Anjali Anand | 12 November 2026

NexGel Enters Note Conversion and Private Placement Deals Ahead of Planned Fountainhead Merger

NexGel, Inc. filed a Form 8-K on November 12, 2026, disclosing agreements entered on November 10, 2026, covering note amendment and conversion arrangements with convertible noteholders and a private placement of common stock and warrants, as part of a recapitalization intended to precede a …

Vinay Lochav | 12 November 2026

Adam Blitzer Joins Rocket Companies Board, Filling Emerson Seat

Rocket Companies, Inc. filed a Form 8-K on November 12, 2026, disclosing the resignation of director Bill Emerson and the appointment of Adam Blitzer as a Class I director effective November 16, 2026.

Manish Choudhary | 12 November 2026
Support

Hi! How can we help you today?

Loading…